摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

pentan-3-yl 2-methylpropanoate | 18599-01-4

中文名称
——
中文别名
——
英文名称
pentan-3-yl 2-methylpropanoate
英文别名
3-pentyl 2-methylpropanoate;3-pentyl 2-methylpropionate;3-pentyl-2-methylpropionate;2-Methyl-propionsaeure-3-pentylester
pentan-3-yl 2-methylpropanoate化学式
CAS
18599-01-4
化学式
C9H18O2
mdl
——
分子量
158.241
InChiKey
GADXZGHRVFDIPV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    165.2±8.0 °C(Predicted)
  • 密度:
    0.872±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    11
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • PRODRUGS OF NH-ACIDIC COMPOUNDS: ESTER, CARBONATE, CARBAMATE AND PHOSPHONATE DERIVATIVES
    申请人:Blumberg Laura Cook
    公开号:US20110319422A1
    公开(公告)日:2011-12-29
    The invention provides a method of sustained delivery of a lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug by administering to a patient an effective amount of a prodrug compound of the invention wherein upon administration to the patient, release of the parent drug from the prodrug is sustained release. Prodrug compounds suitable for use in the methods of the invention are labile conjugates of parent drugs that are derivatized through carbonyl linked prodrug moieties. The prodrug compounds of the invention can be used to treat any condition for which the lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug is useful as a treatment.
    该发明提供了一种持续释放内酰胺、亚酰胺、酰胺、磺胺、碳酸酯或尿素含有母药的方法,通过向患者施用该发明的一种前药化合物的有效量,在向患者施用后,从前药中释放母药是持续释放的。适用于该发明方法的前药化合物是母药的不稳定结合物,通过羰基连接的前药基团进行衍生化。该发明的前药化合物可用于治疗任何需要内酰胺、亚酰胺、酰胺、磺胺、碳酸酯或尿素含有母药作为治疗的情况。
  • Studies aimed at enhancement of reactivity and enantioselectivity of a lithium ester enolate using a chiral tridentate lithium amide
    作者:Mostafa Ahmed Hussein、Akira Iida、Kiyoshi Tomioka
    DOI:10.1016/s0040-4020(99)00644-4
    日期:1999.9
    chiral amines 7–13 mediated the asymmetric condensation reaction of lithium ester enolate 2 with benzaldehyde p-anisidine imine 3 giving the corresponding β-lactam 4 in up to 75% ee. It became apparent that coexistence of 2 and chiral lithium amides derived from 7–13 is an important factor for the enhancement of the reactivity and enantioselectivity of 2.
    三齿手性胺7-13介导了烯醇锂酯2与苯甲醛对茴香胺亚胺3的不对称缩合反应,从而在75%ee内产生相应的β-内酰胺4。它变得明显的共存2个衍生自和手性氨基化锂7-13为的反应性和对映选择性的的提高的一个重要因素2。
  • Catalytic asymmetric reaction of lithium ester enolates with imines
    作者:Kiyoshi Tomioka、Mostafa Ahmed Hussein、Takeshi Kambara、Hiroki Fujieda、Satoko Hayashi、Yumiko Nomura、Motomu Kanai、Kenji Koga
    DOI:10.1039/a901424a
    日期:——
    An external chiral tridentate amino diether ligand 7 catalyzed the condensation reaction of a lithium ester enolate 2 with an imine 3 to give the enantiomerically enriched β-lactam 4 in high yield.
    外部的手性三叉氨基二醚配体 7 催化了锂酯烯醇 2 与亚胺 3 的缩合反应,从而以高产率得到了对映体富集的 β-内酰胺 4。
  • [EN] PROCESS FOR THE PREPARATION OF ACYLATED SECONDARY ALCOHOL ALKOXYLATES AND SECONDARY ALCOHOL ALKOXYLATES<br/>[FR] PROCÉDÉ DE PRÉPARATION D'ALCOXYLATES D'ALCOOLS SECONDAIRES ACYLÉS ET ALCOXYLATES D'ALCOOLS SECONDAIRES
    申请人:SHELL INT RESEARCH
    公开号:WO2010049465A1
    公开(公告)日:2010-05-06
    A process for the preparation of acylated secondary alcohol alkoxylates, said process comprising : (i) reaction of one or more internal olefins with one or more carboxylic acids in the presence of a catalyst composition in order to form one or more carboxylic acid esters; (ii) reaction of one or more carboxylic acid esters from step (i) with one or more alkylene oxide reactants, in the presence of a catalytically effective amount of a catalyst composition comprising: (a) one or more alkaline earth metal salts of carboxylic and/or hydroxycarboxylic acids and/or hydrates of the former; (b) an oxy-acid selected from sulphuric acid and ortho-phosphoric acid; (c) an alcohol and/or an ester; and/or products of the reciprocal reactions of (a), (b) and/or (c) in order to form one or more acylated secondary alcohol alkoxylates; and optionally (iii) hydrolysis or transesterification of one or more acylated secondary alcohol alkoxylates from step (ii) in order to form one or more secondary alcohol alkoxylates; and a process for making secondary alcohol alkoxy sulphates comprising the steps of: preparing secondary alcohol alkoxylates by the afore-mentioned process; and sulphating the secondary alcohol alkoxylates.
    一种制备酰化二次醇烷氧基化物的方法,该方法包括:(i)在催化剂组成物的存在下,将一种或多种内部烯烃与一种或多种羧酸反应,以形成一种或多种羧酸酯;(ii)在催化剂组成物的存在下,将步骤(i)中的一种或多种羧酸酯与一种或多种烷基氧化物反应,其中催化剂组成物包括:(a)一种或多种碱土金属羧酸和/或羟基羧酸盐和/或其水合物;(b)从硫酸和正磷酸中选择的氧酸;(c)一种醇和/或一种酯和/或(a),(b)和/或(c)的互反作用产物,以形成一种或多种酰化二次醇烷氧基化物;可选地(iii)水解或酯交换步骤,以形成一种或多种二次醇烷氧基化物。制备二次醇烷氧基硫酸盐的方法包括以下步骤:通过上述方法制备二次醇烷氧基化物;并对二次醇烷氧基化物进行硫酸化。
  • Controlling Factors in Chiral Bisoxazoline-Catalyzed Asymmetric Lithium Ester Enolate-Imine Condensation Producing a .BETA.-Lactam.
    作者:Takeshi KAMBARA、Kiyoshi TOMIOKA
    DOI:10.1248/cpb.48.1577
    日期:——
    A catalytic amount of external chiral bisoxazoline ligand 3a bearing an isopropyl group as a stereocontrolling group catalyzed a reaction of a lithium ester enolate 4b, generated from 3-pentyl 2-methylpropionate, with benzaldehyde anisidine-imine 5 to afford corresponding beta-lactam 6 in higher 70% ee than that obtained by the reaction using a stoichiometric amount of the ligand. A bulkier ligand
    催化量的带有异丙基作为立体控制基团的外部手性双恶唑啉配体3a催化了由2-甲基丙酸3-戊酯生成的烯酸酯锂4b与苯甲醛茴香胺-亚胺5的反应,从而得到相应的β-内酰胺6比使用化学计量的配体通过反应获得的ee高70%ee。带有苯基的较大的配体3d在化学计量和催化反应中分别得到81%和6%的ee。对各种因素的研究表明,混合骨料参与了反应。提出了用于预测不对称感应感的工作模型。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物